Table 1 Patient demographics
Age (1369 Responses): | 57.8 +/− 11.0 |
Sex (n = 1370): | |
Male: | 1140 (83.2%) |
Female: | 230 (16.8%) |
Religion (n = 787): | |
Hindu: | 653 (83.0%) |
Muslim: | 126 (16.0%) |
Sikh: | 6 (0.8%) |
Christian: | 2 (0.3%) |
Education (n = 933): | |
Illiterate: | 232 (24.9%) |
Primary: | 233 (25.0%) |
Secondary: | 256 (27.4%) |
Higher Secondary: | 106 (11.4%) |
Graduate: | 76 (8.1%) |
Post-Graduate: | 30 (3.2%) |
Income per Capita (n = 587)a: | 6000 [0–100,000] |
Smoking Status (n = 1273): | |
Never: | 288 (22.6%) |
Current: | 534 (42.0%) |
Reformed: | 451 (35.4%) |
Smoking Index (n = 1093)b: | 265 [0.25–3500] |
ECOG Performance Status (n = 971): | |
ECOG 0: | 67 (6.9%) |
ECOG 1: | 491 (50.6%) |
ECOG 2: | 272 (28.0%) |
ECOG 3: | 114 (11.7%) |
ECOG 4: | 27 (2.8%) |
KPS Score (n = 1017): | |
KPS < 70: | 232 (22.8%) |
KPS >/ 70: | 785 (77.2%) |
Definitive Diagnostic Study (n = 1289): | |
Bronchoscopy: | 678 (52.6%) |
CT-Guided Lung Biopsy: | 297 (23.0%) |
US-Guided Lung Biopsy: | 116 (9.0%) |
Thoracoscopy: | 53 (4.1%) |
Surgical: | 5 (3.9%) |
Otherc: | 140 (10.9%) |
Pathologic Diagnosis (n = 1370): | |
Adenocarcinoma: | 449 (32.8%) |
Squamous Cell Carcinoma: | 379 (27.7%) |
NSCLC-NOS: | 261 (19.1%) |
Small Cell Carcinoma: | 243 (17.7%) |
Adeno-Squamous Carcinoma: | 6 (0.4%) |
Mesothelioma: | 5 (0.4%) |
Neuroendocrine Tumor: | 9 (0.7%) |
Adenoid cystic Carcinoma: | 10 (0.8%) |
Others: | 8 (0.6%) |
NSCLC Stage at Diagnosis (n = 1026): | |
Stage 1: | 14 (1.4%) |
Stage 2: | 42 (4.1%) |
Stage 3: | 309 (30.1%) |
Stage 4: | 661 (64.4%) |
SCLC Stage at Diagnosis (n = 220): | |
Limited: | 54 (24.5%) |
Extensive: | 166 (75.5%) |